{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T09:31:04Z","timestamp":1773480664730,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.urology.2012.04.006","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T19:22:08Z","timestamp":1340824928000},"page":"169-173","source":"Crossref","is-referenced-by-count":5,"title":["Influence of Opioid Consumption on Serum Prostate-specific Antigen Levels in Men Without Clinical Evidence of Prostate Cancer"],"prefix":"10.1016","volume":"80","author":[{"given":"Seyed Yousef","family":"Hosseini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erfan","family":"Amini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Safarinejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Lashay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir Hossein","family":"Farokhpey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2012.04.006_bib1","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM198710083171501","article-title":"Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate","volume":"317","author":"Stamey","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2012.04.006_bib2","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0022-5347(17)42630-9","article-title":"Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy","volume":"139","author":"Oesterling","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2012.04.006_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urology.2012.04.006_bib4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10552-007-9083-8","article-title":"Quantifying the role of PSA screening in the US prostate cancer mortality decline","volume":"19","author":"Etzioni","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.urology.2012.04.006_bib5","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.urology.2007.07.063","article-title":"Age-specific prostate-specific antigen reference ranges in Korean men","volume":"70","author":"Choi","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urology.2012.04.006_bib6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.juro.2006.09.063","article-title":"Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening","volume":"177","author":"Moul","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2012.04.006_bib7","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.urology.2005.04.040","article-title":"Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer","volume":"66","author":"Ochiai","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urology.2012.04.006_bib8","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1442-2042.2007.01879.x","article-title":"Body mass index influences prostate-specific antigen in men younger than 60 years of age","volume":"14","author":"Kim","year":"2007","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2012.04.006_bib9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.urology.2007.11.036","article-title":"Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic","volume":"71","author":"Price","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.urology.2012.04.006_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/pros.20704","article-title":"Obesity and screening PSA levels among men undergoing an annual physical exam","volume":"68","author":"Rundle","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2012.04.006_bib11","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1442-2042.2006.01445.x","article-title":"Effect of prostate manipulation on the serum levels of complexed prostate-specific antigen and total prostate-specific antigen","volume":"13","author":"Long","year":"2006","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2012.04.006_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0014-2999(97)01213-2","article-title":"Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors","volume":"24","author":"Kampa","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.urology.2012.04.006_bib13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.yexcr.2003.11.027","article-title":"The opioid agonist ethylketocyclazocine reverts the rapid, non-genomic effects of membrane testosterone receptors in the human prostate LNCaP cell line","volume":"294","author":"Kampa","year":"2004","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.urology.2012.04.006_bib14","first-page":"3748","article-title":"Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP","volume":"51","author":"Young","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2012.04.006_bib15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4158\/EP.6.2.132","article-title":"Testosterone treatment in hypogonadal men: prostate-specific antigen level and risk of prostate cancer","volume":"6","author":"Guay","year":"2000","journal-title":"Endocr Pract"},{"key":"10.1016\/j.urology.2012.04.006_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-3806(91)90149-D","article-title":"Morphine alters astrocyte growth in primary cultures of mouse glial cells: evidence for a direct effect of opiates on neural maturation","volume":"60","author":"Stiene-Martin","year":"1991","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1016\/j.urology.2012.04.006_bib17","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0361-9230(91)90212-3","article-title":"Localization of preproenkephalin A mRNA in the neonatal rat retina","volume":"27","author":"Isayama","year":"1991","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.urology.2012.04.006_bib18","first-page":"1033","article-title":"Opioids induce while nicotine suppresses apoptosis in human lung cancer cells","volume":"5","author":"Maneckjee","year":"1994","journal-title":"Cell Growth Differ"},{"key":"10.1016\/j.urology.2012.04.006_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0014-2999(95)00703-2","article-title":"The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors","volume":"296","author":"Hatzoglou","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.urology.2012.04.006_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/pros.2990140308","article-title":"Regional distribution of opioidergic nerves in human and canine prostates","volume":"14","author":"Aum\u00fcller","year":"1989","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2012.04.006_bib21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0014-5793(97)00346-3","article-title":"Testosterone induces Ca2+ influx via non-genomic surface receptors in activated T cells","volume":"407","author":"Benten","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.urology.2012.04.006_bib22","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1096\/fj.02-0131fje","article-title":"The human prostate cancer cell line LNCaP bears functional membrane testosterone receptors that increase PSA secretion and modify actin cytoskeleton","volume":"16","author":"Kampa","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.urology.2012.04.006_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/jc.2004-0929","article-title":"Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence","volume":"90","author":"Bliesener","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.urology.2012.04.006_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2605.2007.00824.x","article-title":"Hypogonadism in men receiving methadone and buprenorphine maintenance treatment","volume":"32","author":"Hallinan","year":"2009","journal-title":"Int J Androl"},{"key":"10.1016\/j.urology.2012.04.006_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2605.1988.tb00984.x","article-title":"Gonadal function in male heroin and methadone addicts","volume":"11","author":"Ragni","year":"1988","journal-title":"Int J Androl"},{"key":"10.1016\/j.urology.2012.04.006_bib26","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.juro.2011.04.065","article-title":"Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory","volume":"186","author":"Khera","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2012.04.006_bib27","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.urology.2006.08.1058","article-title":"Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng\/mL or less","volume":"68","author":"Morgentaler","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.urology.2012.04.006_bib28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/pros.1046","article-title":"High-grade prostate cancer is associated with low serum testosterone levels","volume":"47","author":"Schatzl","year":"2001","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2012.04.006_bib29","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1097\/01.ju.0000158040.33531.e7","article-title":"Testosterone as a predictor of pathological stage in clinically localized prostate cancer","volume":"173","author":"Isom-Batz","year":"2005","journal-title":"J Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429512003925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429512003925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T06:15:43Z","timestamp":1561875343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429512003925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0090429512003925"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2012.04.006","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}